Recent advances in targeting LRRK2 for Parkinson’s disease treatment
Abstract Parkinson’s disease (PD) is a neurodegenerative disease with severe movement problems. Current treatments mainly focus on symptom management by reducing dopaminergic pathways in the brain. Despite these therapies, ongoing disease progression undermines the effectiveness of prevalent approac...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2025-07-01
|
| Cyfres: | Journal of Translational Medicine |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s12967-025-06354-0 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|